Application value of BIS and S100β combined with Copeptin in patients with acute severe carbon monoxide poisoning.
10.3760/cma.j.cn121094-20201224-00714
- VernacularTitle:BIS与S100β联合Copeptin在急性重度一氧化碳中毒患者中的应用价值
- Author:
Long LI
1
;
Jia LI
1
;
Cheng Guo CHAI
1
;
Jian Jun ZHANG
1
;
Shuang Yang ZHANG
1
Author Information
1. Hengshui People's Hospital EICU, Hengshui 053000, China.
- Publication Type:Journal Article
- Keywords:
Acute severe carbon monoxide poisoning;
Bispectral index;
Carbon monoxide poisoning;
Copeptin;
Prognosis;
Specificprotein 100β
- MeSH:
Biomarkers;
Carbon Monoxide Poisoning;
Creatine Kinase, MB Form;
Humans;
Natriuretic Peptide, Brain;
Peptide Fragments;
Prognosis;
ROC Curve;
S100 Calcium Binding Protein beta Subunit
- From:
Chinese Journal of Industrial Hygiene and Occupational Diseases
2022;40(3):204-208
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the application value of bispectral index(BIS) , specific protein 100β(S100β) combined with Copeptinin patients with acute severe carbon monoxide poisoning (ASCMP). Methods: A total of 256 patients with acute carbon monoxide poisoning admitted to Hengshui People's Hospital from June 2018 to June 2020 were collected, and they were divided into 30 mild cases, 40 moderate cases and 186 severe cases according to the degree of poisoning. Among them, patients with severe carbon monoxide poisoning were divided into a poor prognosis group (20 cases) and a good prognosis group (166 cases) according to whether adverse events occurred. The changes of creatine kinase isoenzyme (CK-MB) , N-terminal precursor B-type brain natriuretic peptide (NT-proBNP) , BIS, S100β, and Copeptin in poisoned patients were measured. Logistic regression analysis and receiver operating characteristic (ROC) curve were used to evaluate the significance of relevant indicators for ASCMP patients. Results: Compared with the mild-to-moderate group, CK-MB, NT-proBNP, S100β, Copeptin increased, and BIS value decreased in the severe group (P< 0.05). 24 hours after admission, compared with the good prognosis group, CK-MB, NT-proBNP, S100β, Copeptin in the poor prognosis group increased, and the BIS value decreased (P<0.05). In the poor prognosis group, CK-MB, NT-proBNP, S100β, and Copeptin at 72 hours after admission were all lower than those at 24 hours after admission, and the BIS value was higher than that at 24 hours after admission (P<0.05). Logistic regression analysis showed that ASCMP patients with increased S100β, Copeptin, and decreased BIS values had an increased risk of adverse events (P<0.05). The ROC curve showed that the area under the curve of the combined detection of BIS, S100β and Copeptin was 0.859, which had a great predictive value for the prognosis of ASCMP patients. Conclusion: BIS, S100β combined with Copeptin detection is of great value for early assessment of ASCMP disease and prognosis prediction.
